Dr. Reddys Labs (RDY) Unit Announces U.S. Availability of ZEMBRACE SymTouch
Tweet Send to a Friend
Promius Pharma LLC, a subsidiary of Dr. Reddy’s Laboratories (NYSE: RDY), announced that ZEMBRACE SymTouch is now commercially available in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
